Skip to content
Medical Health Aged Care, Women

Media alert: Would-be parents urged to take the ‘sliding doors’ genetic screening swab test. embargoed 31102023

Lumi Health 2 mins read

Embargoed media alert: 0500. Tuesday October 31

Attention Producers


“Take the ‘sliding doors’ test”

Australian couples urged to be empowered by informed family planning

Launch of ground-breaking genetic screening service: Lumi Health




From Tuesday October 31, all Australian couples will have access to affordable and timely reproductive genetic screening services through the launch of Lumi Health. Through a simple cheek swab test, would-be Australian parents can find out their chance of having a child with an inherited genetic condition. Lumi health screens for up to 750 severe childhood-onset genetic conditions. 

This ‘sliding doors’ test will empower would-be parents to make informed family planning decisions.

Proposed Interviewees: 

  • Ms Rachael Casella

Lumi Health Ambassador 


Rachael’s seven month old daughter, Mackenzie, died from the debilitating disorder spinal muscular atrophy (SMA) and she is now determined to prevent another parent going through that pain. Her campaigning inspired Mackenzie's Mission and now, the launch of Lumi Health




Dr Dr Alison Archibald



Professor Martin Delatycki AM


Dr Lior Rauchberger


Pioneer reproductive 

genetic counsellor


Clinical Geneticist & researcher

Founder and CEO


Victorian Clinical Genetic Services)


Murdoch Children's Research Institute 



Lumi Health


Lumi Health

Lumi Health




  • Six years ago Rachael and Jonathan Casella lost their beautiful baby girl Mackenzie after a painful battle with the inherited condition spinal muscular atrophy (SMA). 
  • Rachael is determined that every would-be parent should have affordable and equitable access to reproductive genetic screening – empowering them to make informed family planning decisions.
  • Mackenzie’s Mission inspired the launch of Lumi Health, a tri-partnership between myDNA Australia (myDNA), Victorian Clinical Genetic Services (VCGS) and Murdoch Children's Research Institute (MCRI)
  • Lumi Health is aiming to increase access to reproductive carrier screening for all Australians with a simple cheek swab that can be done at home – making testing more available and empowering families in their family planning journey. 
  • From November 01, bulk billing will be available - screening for three of the most common inherited genetic conditions - cystic fibrosis, spinal muscular atrophy and fragile X syndrome.
  • Lumi Health will screen these three conditions for no out-of-pocket cost and will offer extended carrier screening options for up to another 750 inherited conditions, at a significantly reduced cost.


To arrange interview (live-to-air or pre-recorded)


Jannette Cotterell. Executive Counsel Australia

or text mobile: +61 419 204 059. NB other expert geneticists, GPS and parents can be made available


More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.